75N95021Q00424

Submitted by NIDA_Section on
Post Date/ Solicitation Issue Date
Closing Response Date
Proposed Award Date
Project Title
Gibco medium and supplements restock for cell culture
Contracting Office
National Center for Advancing Translational Sciences (NCATS)

Contact Points

Primary Contract Specialist

Andrew
Varley
Andrew.Varley@nih.gov

Secondary Contracting Officer

Kenneth
Goodling
kenneth.goodling@nih.gov
NAICS Code Number
325414
Gibco medium and supplements restock for cell culture.
Small Business Size Standard
1,250 employees
FPDS Classification Code
N/A
Estimated Period of Performance
N/A
Delivery of Goods
14 days after receipt of order
Competition Status
Non-Competitive
Vendor Name
Life Technologies Corporation
Vendor Address
5781 Van Allen Way
Carlsbad, California, 92008
Single-Sole Source Determination
CATS-SCTL has used LifeTechnologies cell culture medium for the majority of cells used in our assays since it’s inception.
Re-optimization of all existing assays would need to be performed if another manufacturer’s medium were to be introduced, and would therefore incur tremendous costs, time and material resources to the government. Life Technologies also provides special discount pricing beyond was the standard hat other vendors are not able to match.
Because of this, we consistently order exclusively with Life Technologies Corporation.
Background/Description of Requirement

Ongoing research projects in SCTL focus on understanding molecular mechanisms regulating stem cell pluripotency and their multi-lineage differentiation capabilities with a focus on defining optimum culture conditions for maintaining pluripotent stem cells and their conversion to homogeneous and mature population of differentiated cells. To achieve these aims, SCTL performed rigorous internal tests of a variety of stem cell culture systems from several vendors and concluded that the Gibco medium and supplements meets our specific requirement, including supporting stem cell pluripotency maintenance, multi-lineage differentiation and 3-D culture. Any cell culture media used in this context must meet specific measurements of purity and consistency from batch to batch to provide consistent cell growth and viability. In addition, numerous batches of cells have been grown using this medium and supplements and the result was consistent and predictable growth resulting in successful assays performed at NIH NCATS.

12587010, B-27 Supplement (50X) minus vitamin A, 50 bottles
A1370701, CTS (Cell Therapy Systems) N-2 Supplement, 25 bottles
A14700, Vitronectin (VTN-N) Recombinant Human Protein Truncated, 50 bottles
A1516401, Essential 6 Medium, 30 bottles
A2858501, Essential 8 Flex Medium Kit, 30 kits

All items must come from the same manufacturer to ensure consistency of the additives, agents, and vitamins across all media. Must be manufactured at a cGMP-compliant facility, registered with the FDA as a medical device manufacturer, certified to ISO 13485 standards.

12587010, 50 bottles
A1370701, 25 bottles
A14700, 50 bottles
A1516401, 30 bottles
A2858501, 30 kits

Interested parties may identify in writing their interest and capability in response to this requirement. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All responses must be received by closing date and must reference the announcement. Responses may be submitted electronically to the attention of the contract specialist. Fax responses will not be accepted.

All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.